Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now full pipeline

Anxiety Disorder: full-pipeline trial registry

7 of 23 indexed Anxiety Disorder trials are currently recruiting.

Corpus placement: #724 of 28,707 conditions by registered trial count.

23 US clinical trials · 7 currently recruiting · #724 of 28,707 conditions by registered trial count

Anxiety Disorder: 23 US clinical trials tracked, 7 recruiting.

Anxiety Disorder is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Alliance for Clinical Trials in Oncology, running 2 of these trials.

Enrollment posture brief

Registry condition anxiety-disorder

OPEN 7 | RECR 30% | LATE 5 | EARLY 4 | RANK #724 | SPON 2

Nearest open-share peer: Clear Cell Renal Cell Carcinoma (30% recruiting · 46 trials)

Burkitt Lymphoma73.9%Breast Cancer Stage II47.8%Advanced Non-Small-Cell Lung39.1%Anxiety Disorder (this)30%Barrett's Esophagus26.1%
Open-enrollment share among volume-matched conditions near Anxiety Disorder

Anxiety Disorder lists 7 open slots (30% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Anxiety Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Anxiety Disorder is recruiting below its size-band peers.

    7 of 23 indexed trials (30.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Anxiety Disorder trials is spread across many organizations.

    Alliance for Clinical Trials in Oncology accounts for 2 of 23 trials (8.7%). 21 distinct sponsors appear on at least one study for this condition label.

  3. Most Anxiety Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 21 trials that report a genuine target (sentinel values excluded). 13 of those (61.9%) plan for fewer than 100 participants.

  4. Anxiety Disorder research is mostly interventional.

    21 interventional and 2 observational studies make up this index (91.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 24Phase 32Phase 43

Open and recent trials

23 total, page 1 of 1

RECRUITING NA 1,500 participants

Unified Protocol: Community Connections

University of Miami

NCT06038721

RECRUITING NA 501 participants

Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

Bradley Hospital

NCT06934525

RECRUITING Phase 2 112 participants

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

Mclean Hospital

NCT05232032

RECRUITING NA 60 participants

Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Duke University

NCT06333925

RECRUITING NA 40 participants

Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use

VA Office of Research and Development

NCT04871100

RECRUITING NA 25 participants

Low-Intensity Focused Ultrasound and the Complex Patient

Virginia Polytechnic Institute and State University

NCT06297200

RECRUITING NA 24 participants

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Mayo Clinic

NCT07221409

ACTIVE NOT RECRUITING NA 889 participants

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Canadian Cancer Trials Group

NCT00819208

ACTIVE NOT RECRUITING 1 participants

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

M.D. Anderson Cancer Center

NCT04743466

COMPLETED 3,655 participants

Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

National Institute of Mental Health (NIMH)

NCT04339790

COMPLETED Phase 3 880 participants

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Cephalon

NCT00236015

COMPLETED Phase 3 405 participants

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Alliance for Clinical Trials in Oncology

NCT02349412

COMPLETED Phase 4 142 participants

Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety

National Institute of Mental Health (NIMH)

NCT02153944

COMPLETED Phase 4 50 participants

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

Massachusetts General Hospital

NCT00113295

COMPLETED NA 50 participants

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

SWOG Cancer Research Network

NCT01453452

COMPLETED Phase 2 41 participants

Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)

Dennis Charney

NCT00749203

COMPLETED Phase 2 39 participants

Baclofen for Treating Anxiety and Alcoholism

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NCT01751386

COMPLETED NA 33 participants

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Ohio State University Comprehensive Cancer Center

NCT01929720

COMPLETED Phase 2 21 participants

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

NCT00005850

COMPLETED Phase 4 17 participants

Ketamine Infusion for Adolescent Depression and Anxiety

Yale University

NCT02579928

COMPLETED NA 15 participants

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

University of Wisconsin, Madison

NCT02096783

COMPLETED NA

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Gary Morrow

NCT00022074

COMPLETED NA

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Memorial Sloan Kettering Cancer Center

NCT00014482

Phase Distribution

PhaseTrial count
Phase 2 4
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Anxiety Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

counseling intervention Other
3 trials
exercise intervention Behavioral
2 trials
quality-of-life assessment Procedure
2 trials
questionnaire administration Other
2 trials
Midazolam Drug
2 trials
Ketamine Drug
2 trials
Placebo Drug
2 trials
Cognitive-behavioral therapy for worry, uncertainty & insomnia Behavioral
1 trials

US sites by state

Facility locations filed on Anxiety Disorder trials. A trial with sites in several states counts in each.

North Carolina 5 trials
New York 4 trials
Michigan 4 trials
Maryland 4 trials
Massachusetts 4 trials
Illinois 4 trials
Florida 4 trials
California 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Anxiety Disorder page

23 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anxiety Disorder condition card totals 23 registered trials; most-linked intervention counseling intervention; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.